News

Patient enrollment in the Phase II clinical trial will be initiated as soon as possible, according to the company. AC-201 has shown the ability to inhibit the production

The license agreement replaces the prior development and collaboration agreement, under which the two firms were jointly developing ONT-380. Under the license deal, Oncothyreon will pay Array $20m

For three years, the vaccine has been available in trivalent formulation and now it is available in a quadrivalent formulation to help protect against four strains of influenza

The US Food and Drug Administration (FDA) and European Medicines Agency (EMA) have also granted orphan drug designation for selinexor to treat patients with DLBCL. The Phase IIb

The US FDA has also granted fast track designation to defibrotide for the treatment of severe VOD. In its severe form, VOD can be life-threatening and is related

NSCLC occurs when cancer cells form in the lung’s tissues. According to estimates by the National Cancer Institute, about 224,210 individuals in the US are expected to be

If approved, the trial will evaluate the safety and tolerability of increasing doses of Nu-3 when applied topically as well as collect data on the changes in the

Under the deal, X-Chem will deploy its drug discovery engine, which is based on an ultra-large, high-diversity library in excess of 100 billion molecules, to identify new drug

Under the deal, the two parties will establish scalable processes for manufacturing recombinant adeno-associated viral (rAAV) vector products using current good manufacturing practices (cGMP). The deal will combine